Page 122 - CSIR-IGIB Annual Report 2020-21
P. 122

to diagnose at the early stage and distinguish from   active Hp  tetramer accompanied by increased
            other joint diseases, thus leading to progression of   levels of free hemoglobin indicated  the poor
            the  disease  which results in joint stiffness and   clearance of free  hemoglobin in patients with
            cartilage damage. The early detection by a specific   severe OA.  The  prime factor responsible for
            biomarker  may be helpful in timely initiation of   decreased Hp tetramer in OA serum could be the
            available therapy as well as new treatment          presence of autoantibody against the beta subunit
            approach to mitigate the disease progression. We    of Hp monomer. LRG1  has also  been found as
            have applied an advanced proteomic approach to      another important significant up regulated protein
            find the differentially expressed proteins and      in OA plasma. Further study will be carried out to
            check their potential role in disease progression   find the role played by the LRG1 in pathogenesis
            Haptoglobin  (Hp)  has been found to  be  an        of OA. The combined study of all other identified
            important factor in regulating  hemoglobin          significant differential proteins apart from Hp and
            homeostasis and inflammation in severely            LRG1 will  be studied for their significant
            affected  knee OA  patients. Down regulation of     contribution in understanding the etiology of OA.


            Publications

            Oxidative stress in autoimmune diseases: An under dealt malice. Ramani S, Pathak A, Dalal V, Paul A, Biswas S. Curr
            Protein Pept Sci. 2020;21(6):611-621.

            In silico studies on the phytochemical components of Murraya koenigii targeting TNF-α in rheumatoid arthritis, Deeksha
            Kaloni, Debolina Chakraborty, Archana Tiwari, Sagarika Biswas, Journal of Herbal Medicine, 2020, Volume 24, 100396,
            ISSN 2210-8033

            Synovial Fluid cell proteomic analysis identifies up regulation of ΑlphaTaxilin proteins in rheumatoid arthritis: a potential
            prognostic marker, Ashish Sarkar1, Shivani Sharma1, Prachi  Agnihotri1, Tanmoy Sarkar1,  Pooja Kumari1,
            RajeshMalhotra2, Barun Datta3, Vijay Kumar2, Sagarika Biswas1*. J Immunol Res. 2020 Apr 23;2020:4897983.

            Therapeutic potential of Dracaena cinnabari Balf. f. on high fat diet fed rats, Rupsi Kharb1, Prachi Agnihotri1 and Sagarika
            Biswas. Academia Journal of Medicinal Plants 8(11): 159-170, November 2020, IF 2.6

            Plasma Proteome Profiling of Coronary Artery Disease Patients: Downregulation of Transthyretin-an important event.
            Monu,  Kharb  R,  Sharma A, Chaddar MK, Yadav  R, Agnihotri P, Kar A, Biswas  S. Mediators Inflamm. 2020  Nov
            10;2020:3429541.

            A mechanistic insight of phytoestrogens used for rheumatoid arthritis: An evidence-based review. Chakraborty D, Gupta
            K, Biswas S. Biomed Pharmacother. 2021 Jan;133:111039.

            A review on the efficacy of phytomedicines for rheumatoid arthritis, Deeksha Kaloni1, Debolin Chakraborty1,2, , Sagarika
            Biswas1*, Academia Journal of Medicinal Plants, 2021,Vol 21 , Issue 6, Page: [611 - 621], IF 2.6

            Post translational modification and its pathologic association in rheumatoid arthritis: A brief perspective. Vasudevan V,
            Agnihotri P, Biswas S. Curr Protein Pept Sci. 2021;22(7):548-558.

            Biomarkers of joint damage in osteoarthritis: current status and future directions. Kumavat R, Kumar V, Malhotra R,
            Pandit H, Jones E, Ponchel F, Biswas S. Mediators Inflamm. 2021 Mar 9;2021:5574582.

            Poor  clearance  of  free hemoglobin due to lower active haptoglobin availability is associated  with osteoarthritis
            inflammation. Sarkar A, Monu, Kumar V, Malhotra R, Pandit H, Jones E, Ponchel F, Biswas S. J Inflamm Res. 2021 Mar
            18;14:949-964.




               Annual Report 2020-21                                                                      119
   117   118   119   120   121   122   123   124   125   126   127